| |
| |
|
| Insider
Information: |
Smolokowski Wiaczeslaw |
| Relationship: |
10% Owner |
| City: |
Switzerland |
| State: |
G4 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,848,632 |
|
|
Indirect Shares
|
10,258,079 |
|
|
| Direct
Value |
$39,754,290 |
|
|
|
Indirect Value
|
$11,642,920 |
|
|
| Total
Shares |
20,106,711 |
|
|
| Total
Value |
$51,397,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-4.0
|
| Percentage
Gain/Loss : |
 -26.2%
|
-230.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Karyopharm Therapeutics Inc. |
KPTI |
10% Owner |
2019-02-28 |
6,000,000 |
2013-11-12 |
10,258,079 |
Premium* |
|
|
Acrivon Therapeutics, Inc. |
ACRV |
10% Owner |
2023-06-26 |
3,848,632 |
2022-11-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2013-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,258,079 |
10,258,079 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2013-11-12 |
4 |
A |
$0.00 |
$0 |
I/I |
10,258,079 |
10,258,079 |
0 |
- |
|
| ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
– – • |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,456,597 |
3,856,597 |
0 |
- |
|
| ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
– – • |
2023-06-26 |
4 |
S |
$12.93 |
$207 |
D/D |
(16) |
3,848,632 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-05-13 |
4 |
S |
$8.01 |
$3,203 |
D/D |
(400) |
8,967,732 |
0 |
- |
|
| ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
– – • |
2023-06-14 |
4 |
S |
$12.13 |
$10,832 |
D/D |
(893) |
3,850,704 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2018-08-10 |
4 |
S |
$18.50 |
$12,987 |
D/D |
(702) |
8,261,561 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2018-07-25 |
4 |
S |
$18.52 |
$16,571 |
D/D |
(895) |
8,343,139 |
0 |
- |
|
| ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
– – • |
2023-06-12 |
4 |
S |
$12.34 |
$24,680 |
D/D |
(2,000) |
3,854,597 |
0 |
% |
|
| ACRV |
Acrivon Therapeutics, Inc... |
10% Owner |
– – • |
2023-06-13 |
4 |
S |
$12.30 |
$36,900 |
D/D |
(3,000) |
3,851,597 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2018-07-16 |
4 |
S |
$18.52 |
$49,161 |
D/D |
(2,654) |
8,547,266 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2018-08-08 |
4 |
S |
$18.61 |
$52,098 |
D/D |
(2,800) |
8,329,737 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-06-13 |
4 |
S |
$8.51 |
$60,214 |
D/D |
(7,074) |
8,568,744 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-05-16 |
4 |
S |
$8.01 |
$80,065 |
D/D |
(10,000) |
8,957,732 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2018-09-06 |
4 |
S |
$20.52 |
$98,474 |
D/D |
(4,800) |
7,631,267 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-05-11 |
4 |
S |
$8.41 |
$99,860 |
D/D |
(11,868) |
8,968,132 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-06-08 |
4 |
S |
$9.34 |
$145,186 |
D/D |
(15,541) |
8,605,818 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-06-23 |
4 |
S |
$8.03 |
$151,083 |
D/D |
(18,824) |
8,549,920 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-05-10 |
4 |
S |
$8.14 |
$162,788 |
D/D |
(20,000) |
8,980,000 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-05-19 |
4 |
S |
$8.18 |
$163,644 |
D/D |
(20,000) |
8,873,932 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-05-31 |
4 |
S |
$9.66 |
$165,072 |
D/D |
(17,096) |
8,696,782 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-06-01 |
4 |
S |
$9.64 |
$169,327 |
D/D |
(17,568) |
8,679,214 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2018-07-24 |
4 |
S |
$18.63 |
$170,342 |
D/D |
(9,144) |
8,344,034 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-06-02 |
4 |
S |
$9.65 |
$172,244 |
D/D |
(17,855) |
8,661,359 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
10% Owner |
– – • |
2016-05-26 |
4 |
S |
$9.59 |
$174,287 |
D/D |
(18,182) |
8,753,878 |
0 |
- |
|
68 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
